Synthesis and biological evaluation of oxindoles and benzimidazolinones derivatives

被引:42
作者
Messaoudi, S
Sancelme, M
Polard-Housset, V
Aboab, B
Moreau, P
Prudhomme, M
机构
[1] Univ Clermont Ferrand, CNRS, UMR 6504, Lab SEESIB, F-63177 Clermont Ferrand, France
[2] Aventis Pharma SA, Ctr Rech Paris, Biochem Unit, Oncol Dept, F-94400 Vitry Sur Seine, France
关键词
oxindoles; benzimidazolinones; kinases inhibitors; antimicrobial agents;
D O I
10.1016/j.ejmech.2004.01.001
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The synthesis of new oxindoles and benzimidazolinones derivatives bearing a sugar residue on the aromatic nitrogen is described. The presence of the glycoside moiety should enhance the solubility of these heterocyclic compounds and/or improve the interaction with the active site of the biological targets. The inhibitory activities of these new compounds toward five kinases were examined: KDR (VEGFR-2), FGFR-1, PDGFR-beta, EGFR and Tie 2. Furthermore, the antibacterial activities of the prepared compounds were tested against two Gram-positive bacteria Bacillus cereus and Streptomyces chartreusis, a Gram-negative bacterium Escherichia coli and a yeast Candida albicans. (C) 2004 Elsevier SAS. All rights reserved.
引用
收藏
页码:453 / 458
页数:6
相关论文
共 20 条
[11]   Small molecule tyrosine kinase inhibitors: clinical development of anticancer agents [J].
Laird, AD ;
Cherrington, JM .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2003, 12 (01) :51-64
[12]   OXIDATION OF INDOLES WITH PYRIDINIUM BROMIDE PERBROMIDE A SIMPLE AND EFFICIENT SYNTHESIS OF 7-AZAOXINDOLES [J].
MARFAT, A ;
CARTA, MP .
TETRAHEDRON LETTERS, 1987, 28 (35) :4027-4030
[13]  
MELNIK SY, 1996, BIOORG KHIM, V22, P467
[14]  
Saudi MNS, 2002, PHARMAZIE, V57, P519
[15]   Synthesis and antibacterial screening of hydrazones, Schiff and Mannich bases of isatin derivatives [J].
Sridhar, SK ;
Saravanan, M ;
Ramesh, A .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2001, 36 (7-8) :615-625
[16]  
SUGEN INC, 1997, Patent No. 9734920
[17]   Discovery of 5-[5-Fluoro-2-oxo-1,2-dihydroindol-(3Z)-ylidenemethyl]-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-diethylaminoethyl)amide, a novel tyrosine kinase inhibitor targeting vascular endothelial and platelet-derived growth factor receptor tyrosine kinase [J].
Sun, L ;
Liang, C ;
Shirazian, S ;
Zhou, Y ;
Miller, T ;
Cui, J ;
Fukuda, JY ;
Chu, JY ;
Nematalla, A ;
Wang, XY ;
Chen, H ;
Sistla, A ;
Luu, TC ;
Tang, F ;
Wei, J ;
Tang, C .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (07) :1116-1119
[18]  
TANG PC, 1999, Patent No. 5886020
[19]  
Toledo LM, 1999, CURR MED CHEM, V6, P775
[20]  
ZINNER VH, 1970, J PRAKT CHEM, V312, P307